Infectious Diseases News and Research

RSS

Maternal smoking during pregnancy increases infant hospitalizations and death

Maternal smoking is associated with both respiratory and non-respiratory infections in infants, resulting in increased risk for hospitalization and death, according to an abstract to be presented Sunday, Oct. 27, at the American Academy of Pediatrics National Conference and Exhibition in Orlando.

22 Oct 2013

UCLA receives $7M grant to investigate links between substance abuse and HIV among minority men

The National Institute on Drug Abuse has awarded UCLA a $7 million grant to investigate the links between substance abuse and HIV among Latino and African-American men who have sex with men.

22 Oct 2013

New collaborative project aims to discover genes underlying rare genetic diseases

...

21 Oct 2013

Inovio Pharmaceuticals begins phase I clinical trial for hepatitis C vaccine

Inovio Pharmaceuticals, Inc. announced today that the safety, tolerability and immunogenicity of its therapeutic vaccine for hepatitis C (INO-8000/VGX-6150) will be studied in a phase I clinical trial in chronically HCV infected patients.

21 Oct 2013

Advaxis announces full exercise of over-allotment option granted to underwriters

Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, today announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 862,500 shares of its common stock and warrants to purchase an additional 431,250 shares (15% of the shares and warrants sold in this offering), at a public offering price of $4.00 per share and $0.001 per warrant, respectively, in connection with its previously announced underwritten public offering of 5,750,000 shares of common stock, and warrants to purchase up to an aggregate of 2,875,000 shares of common stock, bringing the total gross proceeds from the offering to approximately $26,500,000, before deducting underwriting discounts and commissions and other offering expenses payable by Advaxis, Inc.

19 Oct 2013

Medivir announces data from phase III studies of simeprevir in patients co-infected with HCV genotype-1 and HIV-1

Medivir AB (OMX:MVIR-B) today announced preliminary data from two phase III studies conducted by Janssen R&D Ireland evaluating simeprevir in genotype 4 chronic hepatitis C in adult patients with compensated liver disease, and in genotype 1 hepatitis C and HIV-1 co-infected adult patients.

19 Oct 2013

Merck to present pharmacokinetic data on once-daily ISENTRESS at EACS

Merck, known as MSD outside the United States and Canada, is presenting pharmacokinetic data this week on investigational formulations of a once daily dose of ISENTRESS at the 14th European AIDS Conference, sponsored by the European AIDS Clinical Society.

17 Oct 2013

Most U.S. adolescents lack antibodies that may help protect against genital herpes, says study

A new study suggests a growing number of U.S. adolescents lack antibodies that may help protect them later in life against an increasingly important cause of genital herpes. Published in The Journal of Infectious Diseases and available online, the findings show that fewer of today's teens have been exposed in their childhood to herpes simplex virus type 1 (HSV-1), a common cause of cold sores, than U.S. adolescents in previous years.

17 Oct 2013

Scientists identify recessive gene mutation that reduces certain protein affecting brain development

Though worlds apart, four unrelated families have been united in a medical mystery over the source of a rare inherited disorder that results in their children being born with abnormal brain growth and severe functional impairments.

17 Oct 2013

Cambridge professor to speak about nature of viruses at free public lecture at University of Leicester

Former Regius Professor of Physic at the University of Cambridge to deliver public lecture on Monday 21 October

17 Oct 2013

Imaxio Sells Genomics Division To Hybrigenics

...

16 Oct 2013

Trovagene launches pharmaceutical alliance to monitor lung cancer patients' EGFR mutational status

Trovagene, Inc., a developer of cell-free molecular diagnostics, today announced that it will collaborate with a pharmaceutical company to evaluate Trovagene's proprietary, urine-based, cell-free DNA technology for the detection of certain epidermal growth factor receptor mutations associated with lung cancer.

16 Oct 2013

New type of antibiotic kills multidrug-resistant germ common to health care settings

A new type of antibiotic called a PPMO, which works by blocking genes essential for bacterial reproduction, successfully killed a multidrug-resistant germ common to health care settings, UT Southwestern Medical Center researchers report.

16 Oct 2013

Two institutions receive $25M grant from NIH to abet clinical and translational research

Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have received a $25 million grant from the National Institutes of Health (NIH) for the Harold and Muriel Block Institute for Clinical and Translational Research (ICTR) at Einstein and Montefiore.

16 Oct 2013

University of Sydney's free public talk to focus on halting superbug apocalypse

Everyday activities such as kissing, touching and sharing food can lead to the spread of a new kind of superbug that is as dangerous as it is resistant.

15 Oct 2013

Janssen seeks European marketing approval for combination of once-daily darunavir with cobicistat

Janssen-Cilag International NV, today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency seeking approval for a once-daily single tablet fixed-dose antiretroviral combination product containing darunavir, a protease inhibitor developed by Janssen, with cobicistat, a pharmacokinetic enhancer or boosting agent, developed by Gilead Sciences, Inc. for use in combination with other human immunodeficiency virus medicines.

15 Oct 2013

Study explores why girls in minority groups, low-income families don't get HPV vaccine

A new study explores why girls in minority groups and low-income families, who are most at risk for cervical cancer, may not be getting the human papillomavirus or HPV vaccine.

15 Oct 2013

Research finding may help patients to better survive severe infectious diseases

Scientists of Charité - Universitätsmedizin Berlin for the first time have solved the 3-dimensional structure of the protein LBP and it´s genetic variant. This finding may help certain patients to better survive severe infectious diseases. The results have been published in the recent issue of the journal Immunity.

15 Oct 2013

Football-shaped artificial particles teach immune cells to recognize, destroy cancer cells

Researchers at Johns Hopkins have succeeded in making flattened, football-shaped artificial particles that impersonate immune cells. These football-shaped particles seem to be better than the typical basketball-shaped particles at teaching immune cells to recognize and destroy cancer cells in mice.

14 Oct 2013

Researchers discover new approach to tackle global threat of antibiotic drug resistance

Researchers at McMaster University are addressing the crisis in drug resistance with a novel approach to find new antibiotics.

13 Oct 2013

Infectious Diseases News and Research

Maternal smoking during pregnancy increases infant hospitalizations and death

UCLA receives $7M grant to investigate links between substance abuse and HIV among minority men

New collaborative project aims to discover genes underlying rare genetic diseases

Inovio Pharmaceuticals begins phase I clinical trial for hepatitis C vaccine

Advaxis announces full exercise of over-allotment option granted to underwriters

Medivir announces data from phase III studies of simeprevir in patients co-infected with HCV genotype-1 and HIV-1

Merck to present pharmacokinetic data on once-daily ISENTRESS at EACS

Most U.S. adolescents lack antibodies that may help protect against genital herpes, says study

Scientists identify recessive gene mutation that reduces certain protein affecting brain development

Cambridge professor to speak about nature of viruses at free public lecture at University of Leicester

Imaxio Sells Genomics Division To Hybrigenics

Trovagene launches pharmaceutical alliance to monitor lung cancer patients' EGFR mutational status

New type of antibiotic kills multidrug-resistant germ common to health care settings

Two institutions receive $25M grant from NIH to abet clinical and translational research

University of Sydney's free public talk to focus on halting superbug apocalypse

Janssen seeks European marketing approval for combination of once-daily darunavir with cobicistat

Study explores why girls in minority groups, low-income families don't get HPV vaccine

Research finding may help patients to better survive severe infectious diseases

Football-shaped artificial particles teach immune cells to recognize, destroy cancer cells

Researchers discover new approach to tackle global threat of antibiotic drug resistance

Industry Focus: Infectious Diseases eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News